Thermo Fisher Scientific Inc. (TMO) News & Overview - Discounting Cash Flows
TMO
Thermo Fisher Scientific Inc.
TMO (NYSE)

TMO's Business Model

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Sector & Industry Healthcare / Medical - Diagnostics & Research
Website https://www.thermofisher.com
CEO (Chief Executive Officer) Marc N. Casper
Number of Employees
IPO date March 17, 1980

TMO Latest News

Contact
CountryUS
Address168 Third Avenue
CityWaltham
StateMA
Phone781 622 1000
Zip Code02451
Other Identifiers
CIK0000097745
ISINUS8835561023
CUSIP883556102
Open428.62
Previous Close427.76
Volume1.36 Mil.
Average Volume2.84 Mil.
Day’s Range426.08 – 432.9
52 Week Range385.46-627.88
MA (50)410.6776
MA (200)508.13724
Market Cap162.1 Bil.
Shares Out.377.5 Mil.
Earnings DateJul 22, 2025
Beta
Last Dividend
EPS
PE

Industry Competitors for TMO

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us